LifeSteps Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128K Buy
+5,307
New +$139K 0.06% 130
2024
Q2
Sell
-6,314
Closed -$175K 313
2024
Q1
$175K Buy
+6,314
New +$175K 0.13% 88
2023
Q4
Sell
-9,125
Closed -$303K 83
2023
Q3
$303K Buy
9,125
+3
+0% +$106 0.31% 54
2023
Q2
$335K Sell
9,122
-63
-0.7% -$2.45K 0.33% 51
2023
Q1
$375K Sell
9,185
-1,113
-11% -$48.1K 0.4% 46
2022
Q4
$528K Buy
10,298
+1,880
+22% +$90.1K 0.55% 39
2022
Q3
$368K Buy
8,418
+239
+3% +$11.6K 0.41% 48
2022
Q2
$429K Buy
8,179
+201
+3% +$10.2K 0.45% 47
2022
Q1
$413K Sell
7,978
-32
-0.4% -$1.66K 0.31% 55
2021
Q4
$473K Sell
8,010
-715
-8% -$35.4K 0.33% 47
2021
Q3
$375K Hold
8,725
0.29% 55
2021
Q2
$342K Sell
8,725
-6
-0.1% -$233 0.26% 56
2021
Q1
$316K Sell
8,731
-585
-6% -$20.8K 0.26% 61
2020
Q4
$343K Sell
9,316
-166
-2% -$6.09K 0.31% 52
2020
Q3
$330K Buy
9,482
+2,899
+44% +$102K 0.35% 48
2020
Q2
$204K Buy
+6,583
New +$224K 0.24% 71
2020
Q1
Sell
-6,162
Closed -$229K 89
2019
Q4
$229K Buy
+6,162
New +$219K 0.22% 83

Other funds holding PFE

LifeSteps Financial's PFE Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Pfizer (PFE) in Q2 2026: 5,307 shares worth $128K. The stake represents 0.06% of the portfolio and ranks #130 among its holdings. This is a return to the name: LifeSteps Financial previously reported a position in PFE as recently as Q1 2024.

LifeSteps Financial first reported a position in PFE in Q4 2019 and has held it in 17 quarters since. The position peaked at $528K in Q4 2022. 1,190 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LifeSteps Financial held 5,307 shares of Pfizer worth $128K as of Q2 2026.
  • Pfizer was a new LifeSteps Financial position in Q2 2026.
  • Pfizer made up 0.06% of LifeSteps Financial's portfolio in Q2 2026, its #130 holding.
  • LifeSteps Financial first reported a position in Pfizer in Q4 2019 and has held it in 17 quarters since.
  • LifeSteps Financial's Pfizer position peaked at $528K in Q4 2022.
  • 1,190 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.